Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AI, alike, amperometric, analyst, Andrew, app, arbitrator, Astor, augment, backward, begun, Biochemist, bookkeeping, boosted, bought, broken, Cascade, CGM, CIO, copy, Cork, daily, DCU, dealt, deceptive, deconsolidated, dexcom, Diploma, disincentive, disputed, divested, divestment, divesture, doctorate, DPO, drew, edge, EIR, electrochemical, electrode, EMS, engineered, Enterprise, enzyme, EPA, erase, escalate, explicit, exploit, firmware, footprint, forfeited, formulation, FreeStyle, FTC, GDPR, George, globe, grace, grew, Guangzhou, Guilbault, HB, healthy, hereunder, Highbridge, hybrid, hyperglycaemic, hypo, immobilised, incumbent, India, inorganic, inserted, insertion, insider, intel, intelligence, interstitial, IP, irrevocably, Jacqueline, justify, Kehua, Kenya, KHB, Konamite, Lean, legacy, Libre, lifestyle, Limerick, LLP, Luxembourg, Mainstream, membrane, MiCoBioMed, misdemeanour, needle, OCR, OEM, Omidvar, omitted, Oregon, outer, Overnight, paragraph, PCA, pen, penny, perpetual, Pharmacy, phaseout, pivotal, plasma, Pollution, pool, pooling, Prof, pump, quantify, questionnaire, reanalysing, redacted, relayed, renegotiated, restart, reusable, reuseable, Richard, rose, scrapping, secondary, sensor, serum, Shanghai, skin, smaller, smartphone, specialist, Stelo, Subordination, surface, tabletop, tandem, telephone, temporarily, TFEU, Toxic, tracked, tracking, transmitter, TSCA, twenty, unemployment, unfair, unreasonable, USAID, vendor, Wantai, war, waste, Waterford, waveform, wearable, Wilsonville, wire, Wondfo
Removed:
adding, addressed, adult, Amherst, antibody, arose, Asian, attending, automatic, bearing, Budget, bundling, canteen, Carlsbad, clarify, cleaning, Clint, concluding, Congressional, consistency, constituted, construction, contemplated, continuum, covid, Devia, disagreed, distancing, Dried, earn, elimination, enhancement, excise, exiting, faced, facilitated, favour, FDASIA, Fernando, forthcoming, goal, hygiene, jeopardise, Kevin, largest, Lastly, logistical, Lyme, Mardx, MBA, median, medium, Menarini, migration, misdemeanor, multifactor, newborn, North, PAMA, pattern, POC, postponed, pre, predicate, predictability, prioritization, productivity, promulgate, quantification, ratified, rationale, Rayville, reauthorised, rebased, recommending, recover, remained, remediation, resignation, revaluation, rigor, safeguard, sanitizer, Sanjiv, saving, ScopeSmart, sense, separation, sequestration, Severson, steadily, steady, stipulated, subjectivity, Suri, surrendered, susceptible, Tansley, telecommuting, Terence, territory, topic, trillion, unclear, uncommercial, unwinding, urban, USD, wholly, Williamsville, workplace
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Share Capital and Constitution of Trinity Biotech PLC
- 4.11 Execution Version
- 4.15 Execution Version
- 4.17 Exhibit 4.17
- 4.20 Exhibit 4.20
- 4.21 Exhibit 4.21
- 12.1 Exhibit 12.1
- 12.2 Exhibit 12.2
- 13.1 Exhibit 13.1
- 13.2 Exhibit 13.2
- 15.1 Exhibit 15.1
- 99.7 Exhibit 99.7
- Download Excel data file
- View Excel data file
Associated TRIB transcripts
TRIB similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We have issued our report dated April 30, 2024, with respect to the consolidated financial statements included in the Annual Report of Trinity Biotech plc on Form 20-F for the year ended December 31, 2023. We consent to the incorporation by reference of said report in the following Registration Statements of Trinity Biotech plc:
Form Type | File Number | Effective Date |
Form S-8 | 333-182279 | 6/22/2012 |
Form S-8 | 333-195232 | 4/11/2014 |
Form S-8 | 333-253070 | 2/12/2021 |
Form F-3 | 333-239701 | 7/6/2020 |
Form F-3 | 333-264992 | 5/16/2022 |
Form F-3 | 333-267160 | 8/30/2022 |
/s/ GRANT THORNTON |
Dublin, Ireland |
DATE April 30, 2024 |